These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32289501)

  • 101. Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus.
    Heinimäki S; Hankaniemi MM; Sioofy-Khojine AB; Laitinen OH; Hyöty H; Hytönen VP; Vesikari T; Blazevic V
    Vaccine; 2019 Dec; 37(51):7509-7518. PubMed ID: 31585726
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Molecular epidemiology and host genetics of norovirus and rotavirus infections in Portuguese elderly living in aged care homes.
    Piedade J; Nordgren J; Esteves F; Esteves A; Teodósio R; Svensson L; Istrate C
    J Med Virol; 2019 Jun; 91(6):1014-1021. PubMed ID: 30735247
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination.
    Atmar RL; Baehner F; Cramer JP; Lloyd E; Sherwood J; Borkowski A; Mendelman PM;
    J Infect Dis; 2019 Jul; 220(4):603-614. PubMed ID: 31001633
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus Than Sequential Immunization.
    Malm M; Vesikari T; Blazevic V
    Viruses; 2019 Nov; 11(11):. PubMed ID: 31684058
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Norovirus gastroenteritis outbreak with a secretor-independent susceptibility pattern, Sweden.
    Nordgren J; Kindberg E; Lindgren PE; Matussek A; Svensson L
    Emerg Infect Dis; 2010 Jan; 16(1):81-7. PubMed ID: 20031047
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Functional and structural characterization of Norovirus GII.6 in recognizing histo-blood group antigens.
    Cong X; Li HB; Sun XM; Qi JX; Zhang Q; Duan ZJ; Xu Y; Liu WL
    Virol Sin; 2023 Feb; 38(1):56-65. PubMed ID: 36216242
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Noroviruses distinguish between type 1 and type 2 histo-blood group antigens for binding.
    Shirato H; Ogawa S; Ito H; Sato T; Kameyama A; Narimatsu H; Xiaofan Z; Miyamura T; Wakita T; Ishii K; Takeda N
    J Virol; 2008 Nov; 82(21):10756-67. PubMed ID: 18701592
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Association of fucosyltransferase 2 gene with norovirus infection: A systematic review and meta-analysis.
    Hong X; Xue L; Liao Y; Wu A; Jiang Y; Kou X
    Infect Genet Evol; 2021 Dec; 96():105091. PubMed ID: 34610432
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Emergence of Novel Human Norovirus GII.17 Strains Correlates With Changes in Blockade Antibody Epitopes.
    Lindesmith LC; Kocher JF; Donaldson EF; Debbink K; Mallory ML; Swann EW; Brewer-Jensen PD; Baric RS
    J Infect Dis; 2017 Dec; 216(10):1227-1234. PubMed ID: 28973354
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Viral intra-host evolution in immunocompetent children contributes to human norovirus diversification at the global scale.
    Tohma K; Saito M; Pajuelo MJ; Mayta H; Zimic M; Lepore CJ; Ford-Siltz LA; Gilman RH; Parra GI
    Emerg Microbes Infect; 2021 Dec; 10(1):1717-1730. PubMed ID: 34376124
    [TBL] [Abstract][Full Text] [Related]  

  • 111. A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles.
    Tamminen K; Huhti L; Koho T; Lappalainen S; Hytönen VP; Vesikari T; Blazevic V
    Immunology; 2012 Jan; 135(1):89-99. PubMed ID: 22044070
    [TBL] [Abstract][Full Text] [Related]  

  • 112. GII.4 Human Norovirus: Surveying the Antigenic Landscape.
    Mallory ML; Lindesmith LC; Graham RL; Baric RS
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30791623
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Identification of a blockade epitope of human norovirus GII.17.
    Yi Y; Wang X; Wang S; Xiong P; Liu Q; Zhang C; Yin F; Huang Z
    Emerg Microbes Infect; 2021 Dec; 10(1):954-963. PubMed ID: 33929932
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Comparison of age-stratified seroprevalence of antibodies against norovirus GII in India and the United Kingdom.
    Menon VK; George S; Aladin F; Nawaz S; Sarkar R; Lopman B; Gray JJ; Gomara MI; Kang G
    PLoS One; 2013; 8(2):e56239. PubMed ID: 23437102
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Serological correlate of protection against norovirus-induced gastroenteritis.
    Reeck A; Kavanagh O; Estes MK; Opekun AR; Gilger MA; Graham DY; Atmar RL
    J Infect Dis; 2010 Oct; 202(8):1212-8. PubMed ID: 20815703
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Immune Imprinting Drives Human Norovirus Potential for Global Spread.
    Lindesmith LC; Boshier FAT; Brewer-Jensen PD; Roy S; Costantini V; Mallory ML; Zweigart M; May SR; Conrad H; O'Reilly KM; Kelly D; Celma CC; Beard S; Williams R; Tutill HJ; Becker Dreps S; Bucardo F; Allen DJ; Vinjé J; Goldstein RA; Breuer J; Baric RS
    mBio; 2022 Oct; 13(5):e0186122. PubMed ID: 36102514
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Conservation of carbohydrate binding interfaces: evidence of human HBGA selection in norovirus evolution.
    Tan M; Xia M; Chen Y; Bu W; Hegde RS; Meller J; Li X; Jiang X
    PLoS One; 2009; 4(4):e5058. PubMed ID: 19337380
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection.
    Chachu KA; LoBue AD; Strong DW; Baric RS; Virgin HW
    PLoS Pathog; 2008 Dec; 4(12):e1000236. PubMed ID: 19079577
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Comparison of Microneutralization and Histo-Blood Group Antigen-Blocking Assays for Functional Norovirus Antibody Detection.
    Atmar RL; Ettayebi K; Ayyar BV; Neill FH; Braun RP; Ramani S; Estes MK
    J Infect Dis; 2020 Feb; 221(5):739-743. PubMed ID: 31613328
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Profiling of humoral immune responses to norovirus in children across Europe.
    Villabruna N; Izquierdo-Lara RW; Schapendonk CME; de Bruin E; Chandler F; Thao TTN; Westerhuis BM; van Beek J; Sigfrid L; Giaquinto C; Goossens H; Bielicki JA; Kohns Vasconcelos M; Fraaij PLA; Koopmans MPG; de Graaf M
    Sci Rep; 2022 Aug; 12(1):14275. PubMed ID: 35995986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.